Home › Urogenital Cancer
Urogenital Cancer clinical trials recruiting in the U.S.
23 studies for Urogenital Cancer are recruiting participants at sites across the United States.
Cities with the most studies
- Washington, DC6 studies
- Houston, TX6 studies
- Nashville, TN5 studies
- Columbus, OH5 studies
- Durham, NC4 studies
- Boston, MA3 studies
- Orange, CA3 studies
- St. Louis, MO3 studies
- Atlanta, GA3 studies
- Omaha, NE3 studies
- Miami, FL3 studies
- Dallas, TX3 studies
- Ann Arbor, MI3 studies
- Cedar Rapids, IA3 studies
- Queens, NY3 studies
- New York City, NY3 studies
- Los Angeles, CA3 studies
By state
- California10 studies
- Florida6 studies
- Georgia3 studies
- Illinois4 studies
- Iowa3 studies
- Maryland8 studies
- Massachusetts4 studies
- Michigan5 studies
- Minnesota3 studies
- Missouri5 studies
- Nebraska3 studies
- New York4 studies
- North Carolina6 studies
- Ohio7 studies
- South Carolina4 studies
- Tennessee5 studies
- Texas10 studies
- Virginia3 studies
- Wisconsin4 studies
Recently updated studies
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Sep 28, 2026 · NCT03412877Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT06800313Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Sep 22, 2026 · NCT01174121Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT04038619Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05997615A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT04923178Discharge Medication Use Post-Operatively in GU Cancer Patients
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06795087Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT03819296Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06580002A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT07103018Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
RecruitingPhase 1/2
Ages 18 and older · Men · Updated May 14, 2026 · NCT05413850Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 8, 2026 · NCT07215624Feasibility Study of CBCT for IGRT in Cancer Patients
Recruiting
Ages 18 and older · All sexes · Updated Mar 13, 2026 · NCT06681233Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 3, 2026 · NCT07447050Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT04354064Gender Related Coping and Survivorship for Genitourinary Cancers
RecruitingObservational study
Ages 18 and older · Women · Updated Oct 3, 2025 · NCT05649306Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
RecruitingObservational study
All ages · All sexes · Updated Aug 15, 2025 · NCT0540616718F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
RecruitingPhase 4
Ages 18 and older · Men · Updated Nov 27, 2024 · NCT06706921From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.